Cue Biopharma, Inc. CUE

$CUE While I voted against it… Gemini thinks a R/S is needed to get more institutional investors in… many can’t buy us at this price apparently.

$CUE While I don’t like the thought of a reverse split, it’s actually the best move for institutional investors to be able to get in and buy CUE

$CUE Overall, Ms. Warren did a great job. You can hear in the voices of her and the 2 scientists that they’re excited about the performance and opportunity of CUE-401. Once we get the IND submitted, approved, reverse split to occur, then we will get the attention of Big investors and Big Pharma.

$CUE can we hire these two scientists to present going forward… our Chief Scientist makes me sleepy.

$CUE You are killing it this morning @Lynker ?

$CUE April 7th can’t get here fast enough…

$CUE We’ve got a long way to go, but I’ve liked the increase in visibility and transparency the company has provided via X and PRs. One day it will rip and I’ll be ready for that day!

$CUE The more I read up on this CEO transition, the more I like this move… she’s essential made all the deals we have and has a history of business development.

Gemini thinks this is exactly what we need, that Oz was a ghost.

I think the virtual R&D day is going to be a catalyst here and the filing this afternoon confirmed the 2H CUE-401 is on track

$CUE I guess the positive here is that Oz started in September, never held a conference call, no public appearances… I actually messaged CUE on X to see if the guy was even real! ?

$CUE ?… let’s go Ms. Warren!!